AION Labs

"לא רציתי להיות יותר שכיר חרב": המנכ"ל שנפצע בגבול עזה ועשה שינוי globes.co.il/news/article.a…

Huge congratulations to our @AionLabs own and @WeizmannScience PhD candidate Yumi Minyi Yao for being selected to be in @Forbes 30 under 30! forbes.co.il/rankings/2026u…

תודה רבה @roy_katz על ההזדמנות לדבר על AI בפיתוח תרופות, על איך אנחנו מקימים חברו ב @AionLabs וההזדמנות של ישראל להיות מקור חדשנות לביוטק העולמי 🇮🇱💪🧬 @tv10israel

Congratulations to Profs. Yifat Merbl of the Department of Systems Immunology and Schraga Schwartz of the Department of Molecular Genetics, upon being awarded the ERC Proof of Concept 2026 #ERCPoC @ERC_Research @YMerbl @SchragaSchwartz

@NucleateHQ Israel 🇮🇱 was founded just 4 years ago. We were introduced to the #community by @liyamchitayat. Since then, they have built a true national powerhouse for the #biotech industry in Israel 🇮🇱 with groups on all major Israeli Universities where cutting edge scientific research happens. We at @AionLabs have been proud to partner with them from inception and watch them grow. It was therefore very special for me to be invited to speak at their annual activator event, where I share the blueprint for how we can build the Israeli #Biotechnology #Ecosystem to be on of the top 10 in the world within 10 years. 💪🇮🇱🧬 Because if you have a clear vision, plan and great people to pull it off: “If you will it, It is no Dream”

At @AionLabs we pride ourselves as being a learning organization. I make mistakes. We make mistakes, "we learn from what works. We learn from what doesn't work, especially, and try to not make the same mistake twice." We're blessed with shareholders and partners that support this organizational culture. This is one of the topics we discussed in part 3 of The #Biotech #Startups #Podcast I held with @jonchee_excedr of @ExcedrInc . We also touched on: 🎙️ How the AION Labs partnership came together with our founding partners @pfizer @AstraZeneca @merckgroup @TevaUSA @awscloud and #ibf 🎙️ The #innovation model of #biomedx that we built on and adapted as our venture studio model 🎙️ The @ISRLInnovation #bioconvergence program 🎙️ The lessons learned from the first startup we had to shut down and the story behind the successful sale of our portfolio company CombinAble.AI to @insitro Apple Podcasts: apple.co/3zdned3 Spotify: spotf.fi/JNVNqlI YouTube: lnkd.in/d6knSSRf #biotechnology #lifesciences #podcast

סיכום מעולה של @galiw2 ב @globesnews לשיחה שקיימנו עם משקיעים מובילים מישראל 🇮🇱 ארה״ב 🇺🇸 ואירופה 🇪🇺 בכנס ביומד השנתי שניסינו לפענח את המיתוסים שסטארטאפים ישראלים נאחזים בהם, וסוגי החברות שמצליחים לגייס, ואלו שלא - וגם אלו חברות המשקיעים מרגישים ש״פספסו״ @ShaharTzafrir @Pitango @TLV_Partners @TriventuresVC @EntreeCap @AionLabs globes.co.il/news/article.a…

Loved getting very personal in Part 1 of this conversation with @jonchee_excedr of @ExcedrInc on their #Biotech #Startups #podcast discussing: 🎙️ My rule of 3 for how to build a great family, pursue an ambitious career and impact our country and society Hint, its not about work-life balance, rather about focusing on what really matters. 🎙️ My core values that have remained very consistent and guided my career and life decisions since the age of 20 🎙️ How we moved to Israel 🇮🇱 from Ohio 🇺🇲 Hope you enjoy! On Spotify: lnkd.in/eCuVmfaU On Apple: lnkd.in/e9JmV3Rw @AionLabs

One of the most important applications of AI is in improving clinical trials which encompass up to 70% of R&D costs and where most drugs in development fail. On June 17, 4:20pm at @HLTHEVENT Europe in Amsterdam, Recursion CFO Ben Taylor will present on the panel “Trials & tribulations: Exploring the next frontier in evidence generation,” looking at the rise of new clinical models that are shifting the traditional framework – including in silico models, digital twins, synthetic controls, adaptive frameworks, and hybrid or decentralized trials. He’ll be joined by Mati Gill, CEO of @AionLabs; Peter Donnelly, Co-Founder & CEO of Genomics; and Yajing Zhu, Director, Computational RWE at @novonordisk. Moderated by Adama Ibrahim, President, Digital Transformation at Crest Meridian, the panel will explore how clinical trials have evolved, expected breakthroughs on the horizon, and how pharma can prepare for a world where evidence generation is faster, more diverse, and increasingly augmented by technology. 👉 Learn more: hlth.com/events/europe/…

Biotech IPOs in 2025 and 2026 and how they performed so far (From Lifesci)

Thank you @JamesSpiro for hosting me on the Spiro Circle to talk about the opportunities for Israel 🇮🇱 to be a future hub for global biotech innovation 💪🇮🇱🧬

Pharma has been looking for new sources of innovation for the industry globally. Israel can play a role as "a central hub" due to its university research, AI leadership in tech, and capability to work across two scientific disciplines. @AionLabs CEO @matigill explains >

Congratulations to Prof. @jacob_hanna of the Department of Molecular Genetics, upon being awarded the 2026 Dahleh Lectureship and Award at UCSB

Israel’s innovation ecosystem is once again operating under complex circumstances. Escalation and uncertainty affect daily life, teams, families, and routines. And still, across the ecosystem, companies continue to build, serve global customers, raise capital, and create impact. This is resilience in real time. This is Israeli tech. Agile. Relentless. Since October 7th, we have seen founders adjust operating models overnight, leadership teams prioritize employee wellbeing while maintaining performance, and investors reinforce their long-term commitment to Israeli innovation. Israeli tech companies deliver. No Matter What. Together with @ViolaGroup, G-CMO, and Atreo we launched the “No Matter What” page to document how companies sustain business continuity in challenging times, sharing practical insights and leadership lessons from across the field. As we navigate another period of disruption, we invite founders and leaders across the ecosystem to share their experience. -How have you adapted your operations? -How are you supporting your teams during this time? -What lessons or insights can help strengthen the broader Israeli tech community? Startup Nation Central remains committed to supporting the ecosystem, connecting global partners to Israeli innovation and ensuring that even in uncertainty, opportunity continues to move forward. Everything you need to share the message is available in one place. Use the communications kit to communicate clearly, consistently, and confidently, including FAQs, key talking points, ready-to-use social posts, and customizable visuals. Access it here - okt.to/xtrW8b #NoMatterWhat #IsraeliTech #StartupNation

@sncentral_ We are proud to be partners and to take part

One of the most important initiatives of our startup nation, Next October! #NoMatterWhat Noa Zilberman Yizhar Shai

Sat down at @jpmorgan in SF with @MobiHealthNews to discuss behind the scenes of our recent transaction 🤝How it came together so quickly . 🏡 Why I think our startup found a great new home 🇮🇱 The potential for Israel mobihealthnews.com/news/qa-insitr…

Q&A: @Insitro acquires CombinAble.AI @AIONLabs, marking first Israeli exit for #AI #pharma #startup | #MnA buff.ly/dqUGfEe

Great @HIMSS video check in to discuss @AionLabs future himsstv.brightcovegallery.com/detail/videos/…

A U.S.-based AI biotech is expanding into Israel through the acquisition of Israeli innovation. @insitro , founded by Prof. Daphne Koller, is acquiring CombinAbleAI, an Israeli startup advancing AI-driven design and optimization of complex biologics. CombinAbleAI is the first exit from @AionLabs , supported by the Authority’s Technological Innovation Labs Establishment program. discover-pharma.com/insitro-acquir… #AIDrugDiscovery #Biotech #HealthcareInnovation

BioMed X and Harvard Launch XBridge Pilot to Facilitate… otd.harvard.edu/news/biomed-x-…